Abstract:BackgroundCurcumin, extracted from the spice turmeric is commonly used in traditional Chinese and Indian medicine, has attracted increased interest for treating chronic inflammatory diseases owing to its antioxidant and anti-inflammatory properties. It has been reported that curcumin scavenges free radicals and their reactive metabolites due to its antioxidant activity, and blocks the free radical mediated inflammatory responses resulting in its anti-inflammatory activity. However, it has limited medical use due to its low oral bioavailability largely attributed to its low aqueous solubility. Its low intestinal adsorption is exacerbated by its rapid metabolism and excretion. Several approaches including the use of emulsions, micro-/nano-crystallised formulations, liposomes, cyclodextrin-complexes, conjugation with water soluble polymers, self-assembled particles and nanogels have been proposed to improve the oral bioavailability of curcumin. However, these approaches are difficult to manufacture in a large scale and require expensive machinery. The approach in the current work is to develop a cost-effective and scalable solid oral formulation of curcumin with enhanced bioavailability using water soluble polymers. MethodsCurcumin formulations were prepared through melt-granulation process. Curcumin was dissolved in polyethylene glycol (PEG) and PEG-block copolymer. A series of curcumin to PEG and PEG-block copolymer compositions were tested to maximise curcumin aqueous solubility. Loading of different curcuminoids in the formulation and their aqueous solubility was determined using HPLC along with their dissolution profile. The observations from the new curcumin formulations were compared to a commercially available curcumin product.ResultsDissolving curcumin in PEG can ensure its dispersion at molecular level in aqueous environments, the addition of PEG-bloc-copolymer can further stabilise this dispersion thus, resulted in the increased curcumin aqueous solubility. The results demonstrated that the new formulation can deliver 60mg of curcumin per capsule and showed faster and higher rate of release of curcumin in the soluble form both in simulated gastric conditions and intestinal conditions compared to the commercial comparator.ConclusionThe formulations showed enhanced dissolution and were relatively simple to produce. The PEG-block copolymer increased curcumin aqueous solubility by forming a water soluble complex with the drug. Future work involving in vivo supplementation studies are required to confirm these in vitro observations.

Inducing Sustained Release and Improving Oral Bioavailability of Curcumin Via Chitosan Derivatives-Coated Liposomes.

N-trimethyl Chitosan Chloride-Coated Liposomes for the Oral Delivery of Curcumin.

The Stabilization and Release Performances of Curcumin-Loaded Liposomes Coated by High and Low Molecular Weight Chitosan

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

Chitosan Microparticles for Oral Bioavailability Improvement of the Hydrophobic Drug Curcumin

Development and Evaluation of a Novel Phytosome-Loaded Chitosan Microsphere System for Curcumin Delivery.

Liposomes Coated with Thiolated Chitosan As Drug Carriers of Curcumin

Silica-coated Flexible Liposomes As a Nanohybrid Delivery System for Enhanced Oral Bioavailability of Curcumin

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.

Targeting Transportation of Curcumin by Soybean Lipophilic Protein Nano Emulsion: Improving Its Bioaccessibility and Regulating Intestinal Microorganisms in Mice

Pluronics Modified Liposomes for Curcumin Encapsulation: Sustained Release, Stability and Bioaccessibility.

Enhancing Stability and Anti-Inflammatory Properties of Curcumin in Ulcerative Colitis Therapy Using Liposomes Mediated Colon-Specific Drug Delivery System.

Development of curcumin formulations with enhanced bioavailability for oral drug delivery

Hybrid Liposomes Composed of Amphiphilic Chitosan and Phospholipid: Preparation, Stability and Bioavailability As a Carrier for Curcumin.

Chitosan-graft-poly(lactic acid)/CD-MOFs degradable composite microspheres for sustained release of curcumin

Synthesis of N, N, N-trimethyl Chitosan-Based Nanospheres for the Prolonged Release of Curcumin

Improved Bioavailability of Poorly Water-Soluble Drug Curcumin in Cellulose Acetate Solid Dispersion

The Formation of Chitosan-Coated Rhamnolipid Liposomes Containing Curcumin: Stability and In Vitro Digestion

A curcumin oral delivery system based on sodium caseinate and carboxymethylpachymaran nanocomposites

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.